Pasar al contenido principal

NUEVA METODOLOGIA DE DOCKING ENTRE PROTEINAS PARA LA INTERPRETACION DE VARIANTES GENETICAS DE RELEVANCIA PARA LA SALUD HUMANA

PID2019-110167RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Docking-based identification of small-molecule binding sites at protein-protein interfaces

  • Rosell, Mireia
  • Fernández-Recio, Juan
Protein-protein interactions play an essential role in many biological processes, and their perturbation is a major cause of disease. The use of small molecules to modulate them is attracting increased attention, but protein interfaces generally do not have clear cavities for binding small compounds. A proposed strategy is to target interface hot-spot residues, but their identification through computational approaches usually require the complex structure, which is not often available. In this context, pyDock energy-based docking and scoring can predict hot-spots on the unbound proteins, thus not requiring the complex structure. Here, we have devised a new strategy to detect protein–protein inhibitor binding sites, based on the integration of molecular dynamics for the generation of transient cavities, and docking-based interface hot-spot prediction for the selection of the suitable cavities. This integrative approach has been validated on a test set formed by protein–protein complexes with known inhibitors for which complete structural data of unbound molecules and complexes is available. The results show that local conformational sampling with short molecular dynamics can generate transient cavities similar to the known inhibitor binding sites, and that docking simulations can identify the best cavities with similar predictive accuracy as when knowing the real interface. In a few cases, these predicted pockets are shown to be suitable for protein–ligand docking. The proposed strategy will be useful for many protein–protein complexes for which there is no available structure, as long as the the unbound proteins do not deviate dramatically from the bound conformations., This research was funded by the EU European Regional Development Fund (ERDF) through the Program Interreg V-A Spain-France-Andorra POCTEFA (grant PIREPRED), and by the Spanish Ministry of Science and Innovation (grant PID2019-110167RB-I00). M.R. is recipient of an FPI fellowship from the Severo Ochoa program.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

UEP: an open-source and fast classifier for predicting the impact of mutations in protein-protein complexes

  • Amengual-Rigo, Pep
  • Fernández-Recio, Juan
  • Guallar, Victor
Motivation Single protein residue mutations may reshape the binding affinity of protein¿protein interactions. Therefore, predicting its effects is of great interest in biotechnology and biomedicine. Unfortunately, the availability of experimental data on binding affinity changes upon mutation is limited, which hampers the development of new and more precise algorithms. Here, we propose UEP, a classifier for predicting beneficial and detrimental mutations in protein¿protein complexes trained on interactome data. Results Regardless of the simplicity of the UEP algorithm, which is based on a simple three-body contact potential derived from interactome data, we report competitive results with the gold standard methods in this field with the advantage of being faster in terms of computational time. Moreover, we propose a consensus selection procedure by involving the combination of three predictors that showed higher classification accuracy in our benchmark: UEP, pyDock and EvoEF1/FoldX. Overall, we demonstrate that the analysis of interactome data allows predicting the impact of protein¿protein mutations using UEP, a fast and reliable open-source code. Availability and implementation UEP algorithm can be found at: https://github.com/pepamengual/UEP. Supplementary information Supplementary data are available at Bioinformatics online., This work was supported by a predoctoral fellowship from the Government of Catalonia (2018FI_B_00873 to P.A.-R.) and grants from the Spanish government ‘Programa Estatal I+D+i’ (BIO2016-79930-R), (PID2019-110167RB-I00) and (CTQ2016-79138-R), and by grant PIREPRED from the EU European Regional Development Fund program Interreg V-A Spain-France-Andorra (POCTEFA). This work was also received funding from the IBM-BSC Deep Learning Center (2016)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment

  • Lensink, Marc F.
  • Brysbaert, Guillaume
  • Mauri, Théo
  • Nadzirin, Nurul
  • Velankar, Sameer
  • Chaleil, Raphaël A. G.
  • Clarence, Tereza
  • Bates, Paul A.
  • Kong, Ren
  • Liu, Bin
  • Yang, Guangbo
  • Liu, Ming
  • Shi, Hang
  • Lu, Xufeng
  • Chang, Xang
  • Roy, Raj S.
  • Quadir, Farhan
  • Liu, Jian
  • Cheng, Jianlin
  • Antoniak, Anna
  • Czaplewski, Cezary
  • Giełdón, Artur
  • Kogut, Mateusz
  • Lipska, Agnieszka
  • Liwo, Adam
  • Lubecka, Emilia
  • Maszota-Zieleniak, Martyna
  • Sieradzan, Adam K.
  • Ślusarz, Rafał
  • Wesołowski, Patryk A.
  • Zięba, Karolina
  • Carpio Muñoz, Carlos A. del
  • Ichiishi, Eiichiro
  • Harmalkar, Ameya
  • Gray, Jeffrey J.
  • Bonvin, Alexandre M. J. J.
  • Ambrosetti, Francesco
  • Vargas Honorato, Rodrigo
  • Jandova, Zuzana
  • Jiménez-García, Brian
  • Koukos, Panagiotis I.
  • Keulen, Siri van
  • Noort, Charlotte W. van
  • Réau, Manon
  • Roel-Touris, Jorge
  • Kotelnikov, Sergey
  • Padhorny, Dzmitry
  • Porter, Kathryn
  • Alekseenko, Andrey
  • Ignatov, Mikhail
  • Desta, Israel
  • Ashizawa, Ryota
  • Sun, Zhuyezi
  • Ghani, Usman
  • Hashemi, Nasser
  • Vajda, Sandor
  • Kozakov, Dima
  • Rosell, Mireia
  • Rodríguez-Lumbreras, Luis A.
  • Fernández-Recio, Juan
  • Karczynska, Agnieszka
  • Grudinin, Sergei
  • Yan, Yumeng
  • Li, Hao
  • Lin, Peicong
  • Huang, Sheng-You
  • Christoffer, Charles
  • Terashi, Genki
  • Verburgt, Jacob
  • Sarkar, Daipayan
  • Aderinwale, Tunde
  • Wang, Xiao
  • Kihara, Daisuke
  • Nakamura, Tsukasa
  • Hanazono, Huya
  • Gowthaman, Ragul
  • Guest, Johnathan D.
  • Yin, Rui
  • Taherzadeh, Ghazaleh
  • Pierce, Brian G.
  • Barradas-Bautista, Didier
  • Cao, Zhen
  • Cavallo, Luigi
  • Oliva, Romina
  • Sun, Yuanfei
  • Zhu, Shaowen
  • Shen, Yang
  • Park, Taeyong
  • Woo, Hyeonuk
  • Yang, Jinsol
  • Kwon, Sohee
  • Won, Jonghun
  • Seok, Chaok
  • Kiyota, Yasuomi
  • Kobayashi, Shinpei
  • Harada, Yoshiki
  • Takeda-Shitaka, Mayuko
  • Kundrotas, Petras J.
  • Singh, Amar
  • Vakser, Ilya A.
  • Dapkunas, Justas
  • Olechnovic, Kliment
  • Venclovas, Česlovas
  • Duan, Rui
  • Qiu, Liming
  • Xu, Xianjin
  • Zhang, Shuang
  • Zou, Xiaoqin
  • Wodak, Shoshana J.
We present the results for CAPRI Round 50, the fourth joint CASP-CAPRI protein assembly prediction challenge. The Round comprised a total of twelve targets, including six dimers, three trimers, and three higher-order oligomers. Four of these were easy targets, for which good structural templates were available either for the full assembly, or for the main interfaces (of the higher-order oligomers). Eight were difficult targets for which only distantly related templates were found for the individual subunits. Twenty-five CAPRI groups including eight automatic servers submitted ~1250 models per target. Twenty groups including six servers participated in the CAPRI scoring challenge submitted ~190 models per target. The accuracy of the predicted models was evaluated using the classical CAPRI criteria. The prediction performance was measured by a weighted scoring scheme that takes into account the number of models of acceptable quality or higher submitted by each group as part of their five top-ranking models. Compared to the previous CASP-CAPRI challenge, top performing groups submitted such models for a larger fraction (70–75%) of the targets in this Round, but fewer of these models were of high accuracy. Scorer groups achieved stronger performance with more groups submitting correct models for 70–80% of the targets or achieving high accuracy predictions. Servers performed less well in general, except for the MDOCKPP and LZERD servers, who performed on par with human groups. In addition to these results, major advances in methodology are discussed, providing an informative overview of where the prediction of protein assemblies currently stands., Cancer Research UK, Grant/Award Number: FC001003; Changzhou Science and Technology Bureau, Grant/Award Number: CE20200503; Department of Energy and Climate Change, Grant/Award Numbers: DE-AR001213, DE-SC0020400, DE-SC0021303; H2020 European Institute of Innovation and Technology, Grant/Award Numbers: 675728, 777536, 823830; Institut national de recherche en informatique et en automatique (INRIA), Grant/Award Number: Cordi-S; Lietuvos Mokslo Taryba, Grant/Award Numbers: S-MIP-17-60, S-MIP-21-35; Medical Research Council, Grant/Award Number: FC001003; Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: JP19J00950; Ministerio de Ciencia e Innovación, Grant/Award Number: PID2019-110167RB-I00; Narodowe Centrum Nauki, Grant/Award Numbers: UMO-2017/25/B/ST4/01026, UMO-2017/26/M/ST4/00044, UMO-2017/27/B/ST4/00926; National Institute of General Medical Sciences, Grant/Award Numbers: R21GM127952, R35GM118078, RM1135136, T32GM132024; National Institutes of Health, Grant/Award Numbers: R01GM074255, R01GM078221, R01GM093123, R01GM109980, R01GM133840, R01GN123055, R01HL142301, R35GM124952, R35GM136409; National Natural Science Foundation of China, Grant/Award Number: 81603152; National Science Foundation, Grant/Award Numbers: AF1645512, CCF1943008, CMMI1825941, DBI1759277, DBI1759934, DBI1917263, DBI20036350, IIS1763246, MCB1925643; NWO, Grant/Award Number: TOP-PUNT 718.015.001; Wellcome Trust, Grant/Award Number: FC001003
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution

  • Erausquin, Elena
  • Glaser, Fabian
  • Fernández-Recio, Juan
  • Lopez-Sagaseta, Jacinto
A remarkable number of SARS-CoV-2 variants and other as yet unmonitored lineages harbor amino-acid substitutions with the potential to modulate the interface between the spike receptor-binding domain (RBD) and its receptor ACE2. The naturally occurring Q498Y substitution, which is present in currently circulating SARS-CoV-2 variants, has drawn the attention of several investigations. While computational predictions and in vitro binding studies suggest that Q498Y increases the binding affinity of the spike protein for ACE2, experimental in vivo models of infection have shown that a triple mutant carrying the Q498Y replacement is fatal in mice. To accurately characterize the binding kinetics of the RBD Q498Y–ACE2 interaction, biolayer interferometry analyses were performed. A significant enhancement of the RBD–ACE2 binding affinity relative to a reference SARS-CoV-2 variant of concern carrying three simultaneous replacements was observed. In addition, the RBD Q498Y mutant bound to ACE2 was crystallized. Compared with the structure of its wild-type counterpart, the RBD Q498Y–ACE2 complex reveals the conservation of major hydrogen-bond interactions and a more populated, nonpolar set of contacts mediated by the bulky side chain of Tyr498 that collectively lead to this increase in binding affinity. In summary, these studies contribute to a deeper understanding of the impact of a relevant mutation present in currently circulating SARS-CoV-2 variants which might lead to stronger host–pathogen interactions., This work was supported by Ramon y Cajal, Ministry of Science and Innovation, Government of Spain (grant RYC2017-21683 to JL-S) and COVID 19 Ayudas la Investigacio´n, Government of Navarre (Grant 0011-3597-2020-000010 to JL-S). This work was partially supported by grant No. PID2019-110167RB-I00/AEI/10.13039/501100011033 (to JFR). This work was partially funded by Israeli Science Foundation grant 2106/20 (to FG)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction

  • Landras, Alexandra
  • Reger De Moura, Coralie
  • Villoutreix, Bruno O.
  • Battistella, Maxime
  • Sadoux, Aurélie
  • Dumaz, Nicolas
  • Menash, Suzanne
  • Fernández-Recio, Juan
  • Lebbe, Céleste
  • Mourah, Samia
More than 70% of human NRAS melanomas are resistant to MEK inhibitors highlighting the crucial need for efficient therapeutic strategies for these tumors. CD147, a membrane receptor, is overexpressed in most cancers including melanoma and is associated with poor prognosis. We show here that CD147i, a specific inhibitor of CD147/VEGFR-2 interaction represents a potential therapeutic strategy for NRAS melanoma cells. It significantly inhibited the malignant properties of NRAS melanomas ex vivo and in vivo. Importantly, NRAS patient’s-derived xenografts, which were resistant to MEKi, became sensitive when combined with CD147i leading to decreased proliferation ex vivo and tumor regression in vivo. Mechanistic studies revealed that CD147i effects were mediated through STAT3 pathway. These data bring a proof of concept on the impact of the inhibition of CD147/VEGFR-2 interaction on melanoma progression and represents a new therapeutic opportunity for NRAS melanoma when combined with MEKi., This work was supported by La Ligue Nationale contre le Cancer, the Institut National de la Santé et de la Recherche Médicale (INSERM) and La Société Française de Dermatologie. AL was supported by a PhD funding from La Ligue Nationale contre le Cancer and the Spanish Ministry of Science and Innovation (PID2019-110167RB-I00). We thank technological platform of the Institut Recherche Saint-Louis (IRSL) for confocal microscopy analyses and Dr Benoit Souquet for technical support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities

  • Jiménez-Panizo, Alba
  • Alegre-Martí, Andrea
  • Tettey, Theophilus T.
  • Fettweis, Gregory
  • Abella, Montserrat
  • Antón, Rosa
  • Johnson, Thomas A.
  • Kim, Sohyoung
  • Schiltz, R. Louis
  • Núñez-Barrios, Israel
  • Font-Diaz, Joan
  • Caelles, Carme
  • Valledor, Annabel F.
  • Pérez, Paloma
  • Rojas Mendoza, Ana M.
  • Fernández-Recio, Juan
  • Presman, Diego M.
  • Hager, Gordon L.
  • Fuentes-Prior, Pablo
  • Estébanez-Perpiñá, Eva
20 páginas, 7 figuras, The glucocorticoid receptor (GR) is a ubiquitously expressed transcription factor that controls metabolic and homeostatic processes essential for life. Although numerous crystal structures of the GR ligand-binding domain (GR-LBD) have been reported, the functional oligomeric state of the full-length receptor, which is essential for its transcriptional activity, remains disputed. Here we present five new crystal structures of agonist-bound GR-LBD, along with a thorough analysis of previous structural work. We identify four distinct homodimerization interfaces on the GR-LBD surface, which can associate into 20 topologically different homodimers. Biologically relevant homodimers were identified by studying a battery of GR point mutants including crosslinking assays in solution, quantitative fluorescence microscopy in living cells, and transcriptomic analyses. Our results highlight the relevance of non-canonical dimerization modes for GR, especially of contacts made by loop L1-3 residues such as Tyr545. Our work illustrates the unique flexibility of GR's LBD and suggests different dimeric conformations within cells. In addition, we unveil pathophysiologically relevant quaternary assemblies of the receptor with important implications for glucocorticoid action and drug design, E.E.-P. thanks the generosity of the Gemma E. Carretero Fund; MINECO [BFU2017-86906-R, SAF2017-71878-REDT, SAF2015-71878-REDT to E.E.-P., RTI2018-101500-B-I00 to P.F.-P., RTI2018-096735-B-100 to A.R.M., PID2019-110167RB-I00 to J.F.-R., SAF2017-89510-R to A.V.F. and C.C.]; G.L.H thanks the NIH Intramural Research Program; D.M.P was supported by CONICET. Funding for open access charge: Spanish Ministry of Science (MINECO)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PDBe-KB: collaboratively defining the biological context of structural data

  • PDBe-KB consortium
  • Varadi, Mihaly
  • Anyango, Stephen
  • Armstrong, David
  • Berrisford, John
  • Choudhary, Preeti
  • Deshpande, Mandar
  • Nadzirin, Nurul
  • Nair, Sreenath S.
  • Pravda, Lukáš
  • Tanweer, Ahsan
  • Al-Lazikani, Bissan
  • Andreini, Claudia
  • Barton, Geoffrey J.
  • Bednar, David
  • Berka, Karel
  • Blundell, Tom
  • Brock, Kelly P.
  • Carazo, José M.
  • Damborsky, Jiri
  • David, Alessia
  • Dey, Sucharita
  • Dunbrack, Roland
  • Fernández-Recio, Juan
  • Fraternali, Franca
  • Gibson, Toby
  • Helmer-Citterich, Manuela
  • Hoksza, David
  • Hopf, Thomas
  • Jakubec, David
  • Kannan, Natarajan
  • Krivak, Radoslav
  • Kumar, Manjeet
  • Levy, Emmanuel D.
  • London, Nir
  • Macías, José Ramón
  • Srivatsan, Madhusudhan M.
  • Marks, Debora S.
  • Martens, Lennart
  • McGowan, Stuart A.
  • McGreig, Jake E.
  • Modi, Vivek
  • Parra, R. Gonzalo
  • Pepe, Gerardo
  • Piovesan, Damiano
  • Prilusky, Jaime
  • Putignano, Valeria
  • Radusky, Leandro G.
  • Ramasamy, Pathmanaban
  • Rausch, Atilio O.
  • Reuter, Nathalie
  • Rodríguez-Lumbreras, Luis A.
  • Rollins, Nathan J.
  • Rosato, Antonio
  • Rubach, Paweł
  • Serrano, Luis
  • Singh, Gulzar
  • Skoda, Petr
  • Sorzano, Carlos Óscar S.
  • Stourac, Jan
  • Sulkowska, Joanna I.
  • Svobodova, Radka
  • Tichshenko, Natalia
  • Tosatto, Silvio C. E.
  • Vranken, Wim
  • Wass, Mark N.
  • Xue, Dandan
  • Thornton, Janet
  • Sternberg, Michael
  • Orengo, Christine A.
  • Velankar, Sameer
The Protein Data Bank in Europe – Knowledge Base (PDBe-KB, https://pdbe-kb.org) is an open collaboration between world-leading specialist data resources contributing functional and biophysical annotations derived from or relevant to the Protein Data Bank (PDB). The goal of PDBe-KB is to place macromolecular structure data in their biological context by developing standardised data exchange formats and integrating functional annotations from the contributing partner resources into a knowledge graph that can provide valuable biological insights. Since we described PDBe-KB in 2019, there have been significant improvements in the variety of available annotation data sets and user functionality. Here, we provide an overview of the consortium, highlighting the addition of annotations such as predicted covalent binders, phosphorylation sites, effects of mutations on the protein structure and energetic local frustration. In addition, we describe a library of reusable web-based visualisation components and introduce new features such as a bulk download data service and a novel superposition service that generates clusters of superposed protein chains weekly for the whole PDB archive., ELIXIR [IDP implementation study]; Biotechnology and Biological Sciences Research Council via the 3D-Gateway [BB/T01959X/1]; FunPDBe [BB/P024351/1]; European Molecular Biology Laboratory-European Bioinformatics Institute who supported this work; J.D. acknowledges support from the Ministry of Education, Youth and Sport of the Czech Republic [INBIO CZ.02.1.01/0.0/0.0/16_026/0008451]; R.S., K.B. and J.D. also acknowledge support from the Ministry of Education, Youth and Sport of the Czech Republic [ELIXIR-CZ LM2018131]; L.M. acknowledges support from the European Union's Horizon 2020 Programme (H2020-INFRAIA-2018-1) [823839]; Research Foundation Flanders (FWO) [G032816N, G042518N, G028821N]; W.V. acknowledges support from the Research Foundation Flanders (FWO) [G032816N, G028821N]; A.R. acknowledges support from the Fondazione Cassa Di Risparmio di Firenze [24316]; European Commission [101017567]; M.H.C. acknowledges the AIRC project to MHC [IG 23539]; J.F.-R. acknowledges support from the Spanish Ministry of Science and Innovation [PID2019-110167RB-I00]; N.R. acknowledges support from the Norwegian Research Council (Norges Forskningsråd) [288008]; E.D.L. acknowledges support from the European Union's Horizon 2020 research and innovation programme [819318]; M.J.E.S. acknowledges support from the Wellcome Trust [104955/Z/14/Z, 218242/Z/19/Z]. Funding for open access charge: Biotechnology and Biological Sciences Research Council grant [BB/T01959X/1]; Wellcome Trust [104955/Z/14/Z and 218242/Z/19/Z].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

pyDockDNA: A new web server for energy-based protein-DNA docking and scoring

  • Rodríguez-Lumbreras, Luis A.
  • Jiménez-García, Brian
  • Giménez-Santamarina, Silvia
  • Fernández-Recio, Juan
Proteins and nucleic acids are essential biological macromolecules for cell life. Indeed, interactions between proteins and DNA regulate many biological processes such as protein synthesis, signal transduction, DNA storage, or DNA replication and repair. Despite their importance, less than 4% of total structures deposited in the Protein Data Bank (PDB) correspond to protein-DNA complexes, and very few computational methods are available to model their structure. We present here the pyDockDNA web server, which can successfully model a protein-DNA complex with a reasonable predictive success rate (as benchmarked on a standard dataset of protein-DNA complex structures, where DNA is in B-DNA conformation). The server implements the pyDockDNA program, as a module of pyDock suite, thus including third-party programs, modules, and previously developed tools, as well as new modules and parameters to handle the DNA properly. The user is asked to enter Protein Data Bank files for protein and DNA input structures (or suitable models) and select the chains to be docked. The server calculations are mainly divided into three steps: sampling by FTDOCK, scoring with new energy-based parameters and the possibility of applying external restraints. The user can select different options for these steps. The final output screen shows a 3D representation of the top 10 models and a table sorting the model according to the scoring function selected previously. All these output files can be downloaded, including the top 100 models predicted by pyDockDNA. The server can be freely accessed for academic use (https://model3dbio.csic.es/pydockdna)., This work was supported by grant PID2019-110167RB-I00 funded by MCIN/AEI/10.13039/501100011033. BJ-G. is employed by Zymvol Biomodeling on a project which received funding from the European Union’s Horizon 2020 research and innovation programme under Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia’s Agency for Business Competitiveness (ACCIÓ).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance

  • Alegre-Martí, Andrea
  • Jiménez-Panizo, Alba
  • Martínez-Tébar, Adrián
  • Poulard, Coralie
  • Peralta-Moreno, María Nuria
  • Abella, Montserrat
  • Antón, Rosa
  • Chiñas, Marcos
  • Eckhard, Ulrich
  • Piulats, Josep M.
  • Rojas Mendoza, Ana M.
  • Fernández-Recio, Juan
  • Rubio-Martínez, Jaime
  • Romancer, Muriel Le
  • Aytes, Álvaro
  • Fuentes-Prior, Pablo
  • Estébanez-Perpiñá, Eva
Mutations of the androgen receptor (AR) associated with prostate cancer and androgen insensitivity syndrome may profoundly influence its structure, protein interaction network, and binding to chromatin, resulting in altered transcription signatures and drug responses. Current structural information fails to explain the effect of pathological mutations on AR structure–function relationship. Here, we have thoroughly studied the effects of selected mutations that span the complete dimer interface of AR ligand–binding domain (AR-LBD) using x-ray crystallography in combination with in vitro, in silico, and cell-based assays. We show that these variants alter AR-dependent transcription and responses to anti-androgens by inducing a previously undescribed allosteric switch in the AR-LBD that increases exposure of a major methylation target, Arg761. We also corroborate the relevance of residues Arg761 and Tyr764 for AR dimerization and function. Together, our results reveal allosteric coupling of AR dimerization and posttranslational modifications as a disease mechanism with implications for precision medicine., E.E.-P. thanks G. E. Carretero and A. T. Hagler for sponsorships, CaixaImpulse 2018-00018 La Caixa, and 2018-Llavor with 2017SGR1089 (to P.F.-P.; Generalitat de Catalunya). E.E.-P. thanks 2021SGR01433, BFU-Retos2017-86906-R, PDC2021-121688-100, and SAF2017-71878-REDT (Red Nacional de Receptores Nucleares, NurCaMeIn) with SAF2019-REDT-Uroncomol (to A.A.; Red Nacional de Mecanismos Moleculares del Cáncer Urológico, Uroncomol), RTI2018-101500-B-I00 (to P.F.-P.), PID2019-110167RB-I00/AEI/10.13039/501100011033 (to J.F.-R.), and RTI2018-096735-B-100 (to A.R.; MINECO). A.A. thanks PI19/00342 and CPII20/00024 (Instituto de Salud Carlos III), W81XWH-18-1-0193 (Department of Defense), and 2017SGR448 (Generalitat de Catalunya). U.E. acknowledges support from the Spanish Ministry of Science and Innovation (RYC2020-029773-I and PID2021-128682OA-I00). M.N.P.-M. thanks Predocs-UB2020 5760700. J.R.-M. thanks grants 2021SGR00350 and CEX2021-001202-M. C.P. and M.L.R. were supported by financial support from ITMO Cancer of Aviesan within the framework of the 2021-2030 Cancer Control Strategy, on funds administered by Inserm., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001202-M).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discriminating physiological from non-physiological interfaces in structures of protein complexes: A community-wide study

  • Schweke, Hugo
  • Xu, Qifang
  • Tauriello, Gerardo
  • Pantolini, Lorenzo
  • Schwede, Torsten
  • Cazals, Frédéric
  • Lhéritier, Alix
  • Fernández-Recio, Juan
  • Rodríguez-Lumbreras, Luis A.
  • Schueler-Furman, Ora
  • Varga, Julia K.
  • Jiménez-García, Brian
  • Réau, Manon F.
  • Bonvin, Alexandre M. J. J.
  • Savojardo, Castrense
  • Martelli, Pier-Luigi
  • Casadio, Rita
  • Tubiana, Jérôme
  • Wolfson, Haim J.
  • Oliva, Romina
  • Barradas-Bautista, Didier
  • Ricciardelli, Tiziana
  • Cavallo, Luigi
  • Venclovas, Česlovas
  • Olechnovič, Kliment
  • Guerois, Raphael
  • Andreani, Jessica
  • Martin, Juliette
  • Wang, Xiao
  • Terashi, Genki
  • Sarkar, Daipayan
  • Christoffer, Charles
  • Aderinwale, Tunde
  • Verburgt, Jacob
  • Kihara, Daisuke
  • Marchand, Anthony
  • Correia, Bruno E.
  • Duan, Rui
  • Qiu, Liming
  • Xu, Xianjin
  • Zhang, Shuang
  • Zou, Xiaoqin
  • Dey, Sucharita
  • Dunbrack, Roland L.
  • Levy, Emmanuel D.
  • Wodak, Shoshana J.
Reliably scoring and ranking candidate models of protein complexes and assigning their oligomeric state from the structure of the crystal lattice represent outstanding challenges. A community-wide effort was launched to tackle these challenges. The latest resources on protein complexes and interfaces were exploited to derive a benchmark dataset consisting of 1677 homodimer protein crystal structures, including a balanced mix of physiological and non-physiological complexes. The non-physiological complexes in the benchmark were selected to bury a similar or larger interface area than their physiological counterparts, making it more difficult for scoring functions to differentiate between them. Next, 252 functions for scoring protein-protein interfaces previously developed by 13 groups were collected and evaluated for their ability to discriminate between physiological and non-physiological complexes. A simple consensus score generated using the best performing score of each of the 13 groups, and a cross-validated Random Forest (RF) classifier were created. Both approaches showed excellent performance, with an area under the Receiver Operating Characteristic (ROC) curve of 0.93 and 0.94, respectively, outperforming individual scores developed by different groups. Additionally, AlphaFold2 engines recalled the physiological dimers with significantly higher accuracy than the non-physiological set, lending support to the reliability of our benchmark dataset annotations. Optimizing the combined power of interface scoring functions and evaluating it on challenging benchmark datasets appears to be a promising strategy., This study (SJW coordinator) was performed as part of the Implementation Plan (2019-2021) of Activity-2 of the 3DBioInfo Elixir Community (https://elixir-europe.org/communities/3d-bioinfo). We thank Alexander Botzki (VIB Technology Training, Flanders, Belgium) for helping with installing and hosting the project GitHub. G.T., L.P., and T.S. acknowledge the contributions of Gabriel Studer in setting up the AlphaFold pipeline for our analysis, sciCORE at the University of Basel for providing computational resources and system administration support, and funding from the SIB Swiss Institute of Bioinformatics and the Biozentrum PhD Fellowships. D.K. acknowledges supports by the National Institutes of Health (R01GM133840) and the National Science Foundation (DMS2151678, DBI2003635, CMMI1825941, MCB2146026, and MCB1925643). X.W. is recipient of the MolSSI graduate fellowship. A.M.J.J.B. and M.R. acknowledge financial support from the Netherlands eScience Center (ASDI.2016.043), from the Netherlands Organization for Scientific Research (NWO) (TOP-PUNT grant 718.015.001) and from the European Union Horizon 2020 project BioExcel (823830). J.F.-R. acknowledges support by Spanish Ministry of Science (grant PID2019-110167RB-I00 / AEI / 10.13039/501100011033). B. J.-G. is employed by Zymvol Biomodeling on a project which received funding from the European Union's Horizon 2020 research and innovation program under Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia's Agency for Business Competitiveness (ACCIÓ). X.Z. acknowledges the support from NIH/NIGMS (grant R35GM136409). E.D.L. acknowledges support from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No. 819318), by a research grant from A.-M. Boucher, by research grants from the Estelle Funk Foundation, the Estate of Fannie Sherr, the Estate of Albert Delighter, the Merle S. Cahn Foundation, Mrs Mildred S. Gosden, the Estate of Elizabeth Wachsman, the Arnold Bortman Family Foundation. S.D acknowledges Ramalingaswami re-entry Fellowship (March 30th, 2021) from DBT India.O. S_F acknowledges support from the Israel Science Foundation, founded by the Israel Academy of Science and Humanities (grant number 301/2021.J.K.V. is supported by Marie Sklodowska-Curie European Training Network Grant #860517., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of AlphaFold on structure prediction of protein complexes: The CASP15-CAPRI experiment

  • Lensink, Marc F.
  • Brysbaert, Guillaume
  • Raouraoua, Nessim
  • Bates, Paul A.
  • Giulini, Marco
  • Honorato, Rodrigo V.
  • van Noort, Charlotte
  • Teixeira, Joao M. C.
  • Bonvin, Alexandre M. J. J.
  • Kong, Ren
  • Shi, Hang
  • Zhu, Shaowen
  • Yin, Rujie
  • Sun, Yuanfei
  • Shen, Yang
  • Maszota-Zieleniak, Martyna
  • Bojarski, Krzysztof K.
  • Lubecka, Emilia A.
  • Marcisz, Mateusz
  • Danielsson, Annemarie
  • Dziadek, Lukasz
  • Samsonov, Sergey A.
  • Gaardlos, Margrethe
  • Gieldon, Artur
  • Liwo, Adam
  • Slusarz, Rafal
  • Zieba, Karolina
  • Sieradzan, Adam K.
  • Czaplewski, Cezary
  • Kobayashi, Shinpei
  • Miyakawa, Yuta
  • Kiyota, Yasuomi
  • Takeda-Shitaka, Mayuko
  • Olechnovic, Kliment
  • Wallner, Bjorn
  • Valancauskas, Lukas
  • Dapkunas, Justas
  • Venclovas, Ceslovas
  • Yang, Lin
  • Hou, Chengyu
  • He, Xiaodong
  • Guo, Shuai
  • Jiang, Shenda
  • Ma, Xiaoliang
  • Duan, Rui
  • Qui, Liming
  • Xu, Xianjin
  • Lu, Xufeng
  • Zou, Xiaoqin
  • Velankar, Sameer
  • Wodak, Shoshana J.
  • Chang, Shan
  • Liu, Jian
  • Guo, Zhiye
  • Chen, Xiao
  • Morehead, Alex
  • Roy, Raj S.
  • Wu, Tianqi
  • Giri, Nabin
  • Quadir, Farhan
  • Chen, Chen
  • Cheng, Jianlin
  • Del Carpio, Carlos A.
  • Ichiishi, Eichiro
  • Rodríguez-Lumbreras, Luis A.
  • Fernández-Recio, Juan
  • Harmalkar, Ameya
  • Chu, Lee-Shin
  • Canner, Sam
  • Smanta, Rituparna
  • Gray, Jeffrey J.
  • Li, Hao
  • Lin, Peicong
  • He, Jiahua
  • Tao, Huanyu
  • Huang, Sheng-You
  • Roel-Touris, Jorge
  • Jiménez-García, Brian
  • Christoffer, Charles W.
  • Jain, Anika J.
  • Kagaya, Yuki
  • Kannan, Harini
  • Nakamura, Tsukasa
  • Terashi, Genki
  • Verburgt, Jacob C.
  • Zhang, Yuanyuan
  • Zhang, Zicong
  • Fujuta, Hayato
  • Sekijima, Masakazu
  • Kihara, Daisuke
  • Khan, Omeir
  • Kotelnikov, Sergei
  • Ghani, Usman
  • Padhorny, Dzmitry
  • Beglov, Dmitri
  • Vajda, Sandor
  • Kozakov, Dima
  • Negi, Surendra S.
  • Ricciardelli, Tiziana
  • Barradas-Bautista, Didier
  • Cao, Zhen
  • Chawla, Mohit
  • Cavallo, Luigi
  • Oliva, Romina
  • Yin, Rui
  • Cheung, Melyssa
  • Guest, Johnathan D.
  • Lee, Jessica
  • Pierce, Brian G.
  • Shor, Ben
  • Cohen, Tomer
  • Halfon, Matan
  • Schneidman-Duhovny, Dina
We present the results for CAPRI Round 54, the 5th joint CASP-CAPRI protein assembly prediction challenge. The Round offered 37 targets, including 14 homodimers, 3 homo-trimers, 13 heterodimers including 3 antibody-antigen complexes, and 7 large assemblies. On average ~70 CASP and CAPRI predictor groups, including more than 20 automatics servers, submitted models for each target. A total of 21 941 models submitted by these groups and by 15 CAPRI scorer groups were evaluated using the CAPRI model quality measures and the DockQ score consolidating these measures. The prediction performance was quantified by a weighted score based on the number of models of acceptable quality or higher submitted by each group among their five best models. Results show substantial progress achieved across a significant fraction of the 60+ participating groups. High-quality models were produced for about 40% of the targets compared to 8% two years earlier. This remarkable improvement is due to the wide use of the AlphaFold2 and AlphaFold2-Multimer software and the confidence metrics they provide. Notably, expanded sampling of candidate solutions by manipulating these deep learning inference engines, enriching multiple sequence alignments, or integration of advanced modeling tools, enabled top performing groups to exceed the performance of a standard AlphaFold2-Multimer version used as a yard stick. This notwithstanding, performance remained poor for complexes with antibodies and nanobodies, where evolutionary relationships between the binding partners are lacking, and for complexes featuring conformational flexibility, clearly indicating that the prediction of protein complexes remains a challenging problem., Paul A. Bates: This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC0001003), the UK Medical Research Council (FC001003), and the Wellcome Trust (FC001003). Alexandre M. J. J. Bonvin: Financial support from the European Union Horizon 2020, project BioExcel (823830) and from the Netherlands e-Science Center, project IVRESSE (027.020.G13) is acknowledged. Jianlin Cheng: This work was partially supported by US National Science Foundation (grant #: DBI1759934 and IIS1763246), and US National Institutes of Health (grant #: R01GM093123 and R01GM146340). Juan Fernandez-Recio: Spanish Ministry of Science (grant PID2019-110167RB-I00/AEI/10.13039/501100011033). Jeffrey J. Gray: This work was supported by National Institute of Health grant R35-GM141881. Computational resources were provided by the Advanced Research Computing at Hopkins (ARCH) core facility, supported by the National Science Foundation (NSF) grant number OAC1920103. Sheng-You Huang: This work was supported by the National Natural Science Foundation of China to Sheng-You Huang (Grant No: 62072199 and 32161133002). Brian Jimenez-Garcia: Jorge Roel-Touris acknowledges funding from the European Molecular Biology Organization (EMBO) [ALTF 145-2021]; Brian Jimenez-Garcia is employed by Zymvol Biomodeling on a project which received funding from the European Union's Horizon 2020 research and innovation programme under Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia's Agency for Business Competitiveness (ACCIO). Daisuke Kihara: We are grateful for ITaP Research Computing at Purdue University for providing us additional computational resources for this project. This work is partially supported by the National Institutes of Health (R01GM133840, R01GM123055), the National Science Foundation (CMMI1825941, MCB1925643, DBI2146026, IIS2211598, and DBI2003635). Cezary Czaplewski and Jacob C. Verburgt were supported by a National Institute of General Medical Sciences-funded predoctoral fellowship to Cezary Czaplewski and Jacob C. Verburgt (T32 GM132024). Kozakov/Vajda: DMS 2054251 from the National Science Foundation, and R01GM140098, R35GM118078, RM1135136 from the National Institute of Health. Romina Oliva: This research was funded by the KAUST baseline research funding (to Luigi Cavallo) and by MIUR-FFABR “Fondoper il Finanziamento Attivita Base di Ricerca” (to Romina Oliva). Brian G. Pierce: This work was supported by NIH R35 GM144083 (to Brian G. Pierce). Yang Shen: This study was supported by NIH/NIGMS (R35GM124952 to Yang Shen) and NSF (CCF-1943008 to Yang Shen). Portions of this research were conducted with the advanced computing resources provided by Texas A&M High Performance Research Computing. Adam K. Sieradzan: Supported by National Science Center of Poland (Narodowe Centrum Nauki) (NCN), grants UMO2017/25/B/ST4/01026, UMO-2017/26/M/ST4/00044, and UMO-2017/27/B/ST4/00926. Computational resources were provided by (a) the Interdisciplinary Centre of Mathematical and Computational Modelling (ICM) at the University of Warsaw (b) the Centre of Informatics—Tricity Academic Superkomputer & NetworK (CI TASK) in Gdansk, (c) the Polish Grid Infrastructure (PL-GRID), and (d) our Beowulf cluster at the Faculty of Chemistry, University of Gdansk. Ceslovas Venclovas: Research Council of Lithuania (grant S-MIP-21-25). Bjorn Wallner: Wallenberg AI, Autonomous System and Software Program (WASP) and Berzelius from Knut and Alice Wallenberg Foundation (KAW), Swedish Research Council, 2020-03352, The Swedish e-Science Research Center, and Carl Tryggers stiftelse for Vetenskaplig Forskning, 20:453. Lin Yang: The authors acknowledge the financial support from the Science Foundation of the National Key Laboratory of Science and Technology on Advanced Composites in Special Environments, the Fundamental Research Funds for the Central Universities of China. Xiaoqin Zou: This was supported by NIH/NIGMS R35GM136409 to Xiaoqin Zou., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural vulnerability in EPCR suggests functional modulation

  • Erausquin, Elena
  • Rodríguez-Fernández, Adela
  • Rodríguez-Lumbreras, Luis Ángel
  • Fernández-Recio, Juan
  • Dichiara-Rodríguez, María Gilda
  • López-Sagaseta, Jacinto
The endothelial protein C receptor (EPCR) is a fundamental component of the vascular system in mammals due to its contribution in maintaining blood in a non-prothrombotic state, which is crucial for overall life development. It accomplishes this by enhancing the conversion of protein C (PC) into the anticoagulant activated protein C (APC), with this property being dependent on a known EPCR conformation that enables direct interaction with PC/APC. In this study, we report a previously unidentified conformation of EPCR whereby Tyr154, critical for PC/APC binding, shows a striking non-canonical configuration. This unconventional form is incompatible with PC/APC binding, and reveals, for the first time, a region of structural vulnerability and potential modulation in EPCR. The identification of this malleability enhances our understanding of this receptor, prompting inquiries into the interplay between its plasticity and function, as well as its significance within the broader framework of EPCR's biology, which extends to immune conditions., This work was supported by the Ministry of Science and Innovation (Government of Spain): grants Ramón y Cajal RYC-2017-21683 and Generación de Conocimiento PGC2018-094894-B-I00 to JLS and PID2019-110167RB-I00 to JFR. At the time of the study EEA was a receptor of a predoctoral fellowship "Doctorados Industriales" Gobierno de Navarra (0011-1408-2021-000000). We thank the staff of XALOC beamline at ALBA Synchrotron for their assistance with X-ray diffraction data collection., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcription factors form a ternary complex with NIPBL/MAU2 to localize cohesin at enhancers

  • Fettweis, Gregory
  • Wagh, Kaustubh
  • Stavreva, Diana A.
  • Jiménez-Panizo, Alba
  • Kim, Sohyoung
  • Lion, Michelle
  • Alegre-Martí, Andrea
  • Rinaldi, Lorenzo
  • Johnson, Thomas A.
  • Gilson, Elise
  • Krishnamurthy, Manan
  • Wang, Li
  • Ball, David A.
  • Karpova, Tatiana S.
  • Upadhyaya, Arpita
  • Vertommen, Didier
  • Fernández-Recio, Juan
  • Estébanez-Perpiñá, Eva
  • Dequiedt, Franck
  • Hager, Gordon L.
While the cohesin complex is a key player in genome architecture, how it localizes to specific chromatin sites is not understood. Recently, we and others have proposed that direct interactions with transcription factors lead to the localization of the cohesin-loader complex (NIPBL/MAU2) within enhancers. Here, we identify two clusters of LxxLL motifs within the NIPBL sequence that regulate NIPBL dynamics, interactome, and NIPBL-dependent transcriptional programs. One of these clusters interacts with MAU2 and is necessary for the maintenance of the NIPBL-MAU2 heterodimer. The second cluster binds specifically to the ligand-binding domains of steroid receptors. For the glucocorticoid receptor (GR), we examine in detail its interaction surfaces with NIPBL and MAU2. Using AlphaFold2 and molecular docking algorithms, we uncover a GR-NIPBL-MAU2 ternary complex and describe its importance in GR-dependent gene regulation. Finally, we show that multiple transcription factors interact with NIPBL-MAU2, likely using interfaces other than those characterized for GR., This work was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. E.E.-P. thanks the G.E. Carretero Fund. The research was also supported by Spanish Ministry of Science (MINECO) [PID2022-141399-OB-100 to E.E.-P., JDC2022-048702-I to A.J.-P., and JDC2023-051138-I to A.M.-M]. A.U. acknowledges support from awards NIGMS 145313 and NSF 2132922. J.F.-R. thanks the Spanish Ministry of Science (MINECO) PID2019-110167RB-I00/AEI/10.13039/501100011033. Funding to pay the Open Access publication charges for this article was provided by Intramural Research Program of the NIH., Peer reviewed